Education
About Us
Working with TipRanks
Follow Us
Mochida Pharmaceutical Co., Ltd. (JP:4534)
:4534
RESEARCH TOOLSreports
4534 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥2,836.00 - ¥3,625.00
Previous CloseN/A
Volume18.00K
Average Volume (3M)21.17K
Market Cap
¥100.21B
Enterprise Value¥60.88B
Total Cash (Recent Filing)¥53.58B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)18.8
Beta0.59
Next Earnings
Aug 01, 2025EPS EstimateN/A
Next Dividend Ex-Date
Sep 29, 2025Dividend Yield2.72%
Share Statistics
EPS (TTM)2.25
Shares Outstanding36,390,000
10 Day Avg. Volume23,400
30 Day Avg. Volume21,173
Financial Highlights & Ratios
PEG Ratio-27.98
Price to Book (P/B)0.80
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Mochida Pharmaceutical Co., Ltd. News
PremiumCompany Announcements
Mochida Pharmaceutical Approves Takeover Policy and Updates Committee Members
PremiumCompany Announcements
Mochida Pharmaceutical Announces Leadership Changes to Strengthen Management
PremiumCompany Announcements
Mochida Pharmaceutical Continues Takeover Defense Policy
PremiumCompany Announcements
Mochida Pharmaceutical Reports Strong Financial Growth for FY 2025PremiumCompany Announcements
Mochida Pharmaceutical Unveils 25-27 Medium-term Growth Strategy
PremiumCompany Announcements
Mochida Pharmaceutical Reports Robust Profit Growth for 2024
PremiumCompany Announcements
Mochida Pharmaceutical Reports Stable Financial PerformancePremiumCompany Announcements
Mochida Pharmaceutical Sees Mixed Q1 Results, Stable OutlookOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.19%
Mutual Funds
― Other Institutional Investors
94.32% Public Companies and
Individual Investors
4534 FAQ
What was Mochida Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Mochida Pharmaceutical Co., Ltd. lowest stock price was ¥2836.00 and its highest was ¥3625.00 in the past 12 months.
What is Mochida Pharmaceutical Co., Ltd.’s market cap?
Mochida Pharmaceutical Co., Ltd.’s market cap is ¥100.21B.
When is Mochida Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Mochida Pharmaceutical Co., Ltd.’s upcoming earnings report date is Aug 01, 2025 which is in 13 days.
How were Mochida Pharmaceutical Co., Ltd.’s earnings last quarter?
Mochida Pharmaceutical Co., Ltd. released its earnings results on May 12, 2025. The company reported ¥2.25 earnings per share for the quarter, beating the consensus estimate of N/A by ¥2.25.
Is Mochida Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Mochida Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Mochida Pharmaceutical Co., Ltd. pay dividends?
Mochida Pharmaceutical Co., Ltd. pays a Semiannually dividend of ¥40 which represents an annual dividend yield of 2.72%. See more information on Mochida Pharmaceutical Co., Ltd. dividends here
What is Mochida Pharmaceutical Co., Ltd.’s EPS estimate?
Mochida Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mochida Pharmaceutical Co., Ltd. have?
Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding.
What happened to Mochida Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Mochida Pharmaceutical Co., Ltd. reported an EPS of ¥2.25 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Mochida Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4534
Company Description
Mochida Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company engaged in the research, development, manufacture, and sale of pharmaceutical products. The company operates in sectors including pharmaceuticals, medical devices, and healthcare-related products, focusing on areas such as dermatology, cardiovascular medicine, and ophthalmology. Mochida is dedicated to improving health and quality of life through innovative therapies and products.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Shionogi & Co
―
Eisai Co
―